Abudukeyoumu N, Hernandez-Flores T, Garcia-Munoz M, Arbuthnott GW (2019) Cholinergic modulation of striatal microcircuits. Eur J Neurosci 49(5):604–622. https://doi.org/10.1111/ejn.13949
Ade KK, Wan Y, Chen M, Gloss B, Calakos N (2011) An improved BAC transgenic fluorescent reporter line for sensitive and specific identification of striatonigral medium spiny neurons. Front Syst Neurosci 5:32. https://doi.org/10.3389/fnsys.2011.00032
Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci 97(6):2910–2915
Aksenov MY, Aksenova MV, Silvers JM, Mactutus CF, Booze RM (2008) Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology 29(6):971–977. https://doi.org/10.1016/j.neuro.2008.06.003
Aksenova MV, Silvers JM, Aksenov MY, Nath A, Ray PD, Mactutus CF, Booze RM (2006) HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity. Neurosci Lett 395(3):235–239. https://doi.org/10.1016/j.neulet.2005.10.095
Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12(10):366–375
Al-Harthi L, Joseph J, Nath A (2018) Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium. J Neurovirol 24(6):665–669. https://doi.org/10.1007/s13365-018-0691-8
Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2(7):783–787. https://doi.org/10.1038/nm0796-783
Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111(6):529–538. https://doi.org/10.1007/s00401-006-0037-0
Atwood BK, Kupferschmidt DA, Lovinger DM (2014) Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum. Nat Neurosci 17(4):540–548. https://doi.org/10.1038/nn.3652
Banghart MR, Neufeld SQ, Wong NC, Sabatini BL (2015) Enkephalin disinhibits µ opioid receptor-rich striatal patches via δ opioid receptors. Neuron 88(6):1227–1239. https://doi.org/10.1016/j.neuron.2015.11.010
Barbour AJ, Hauser KF, McQuiston AR, Knapp PE (2020) HIV and opiates dysregulate K+-Cl−-cotransporter 2 (KCC2) to cause GABAergic dysfunction in primary human neurons and Tat-transgenic mice. Neurobiol Dis 141:104878
Barbour AJ, Nass SR, Hahn YK, Hauser KF, Knapp PE (2021) Restoration of KCC2 membrane localization in striatal dopamine D2 receptor-expressing medium spiny neurons rescues locomotor deficits in HIV Tat-transgenic mice. ASN Neuro 13:17590914211022088. https://doi.org/10.1177/17590914211022089
Bariselli S, Fobbs WC, Creed MC, Kravitz AV (2019) A competitive model for striatal action selection. Brain Res 1713:70–79. https://doi.org/10.1016/j.brainres.2018.10.009
Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM, Multicenter AIDS Cohort Study (2011) Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav 5(2):77–85. https://doi.org/10.1007/s11682-011-9113-8
Berger JR, Arendt G (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol (oxford, England) 14(3):214–221. https://doi.org/10.1177/026988110001400304
Berger JR, Nath A (1997) HIV dementia and the basal ganglia. Intervirology 40(2–3):122–131. https://doi.org/10.1159/000150539
Birdsong WT, Jongbloets BC, Engeln KA, Wang D, Scherrer G, Mao T (2019) Synapse-specific opioid modulation of thalamo-cortico-striatal circuits. Elife. https://doi.org/10.7554/eLife.45146
Brailoiu GC, Deliu E, Barr JL, Console-Bram LM, Ciuciu AM, Abood ME, Unterwald EM, Brailoiu E (2017) HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens. Drug Alcohol Depend 178:7–14. https://doi.org/10.1016/j.drugalcdep.2017.04.015
Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid β42 and tau levels correlate with AIDS dementia complex. Neurology 65(9):1490. https://doi.org/10.1212/01.wnl.0000183293.95787.b7
Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ, Geurin T, Chauhan A, Reid R, Xu R, Nath A, Knapp PE, Hauser KF (2008) Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 56(13):1414–1427. https://doi.org/10.1002/glia.20708
Buch S, Periyasamy P, Thangaraj A, Sil S, Chivero ET, Tripathi A (2020) Opioid-mediated HIV-1 immunopathogenesis. J Neuroimmune Pharmacol 15(4):628–642. https://doi.org/10.1007/s11481-020-09960-5
Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman B (2016) Neuropsychological, neurovirological and neuroimmune aspects of abnormal GABAergic transmission in HIV infection. J Neuroimmune Pharmacol 11(2):279–293. https://doi.org/10.1007/s11481-016-9652-2
Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM (2006) Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7(10):R100. https://doi.org/10.1186/gb-2006-7-10-r100
Castelo JMB, Courtney MG, Melrose RJ, Stern CE (2007) Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise. Arch Neurol 64(9):1275–1280. https://doi.org/10.1001/archneur.64.9.1275
Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 42(2):869–878. https://doi.org/10.1016/j.neuroimage.2008.05.011
Chilunda V, Calderon TM, Martinez-Aguado P, Berman JW (2019) The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Brain Res 1724:146426. https://doi.org/10.1016/j.brainres.2019.146426
Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9(2):251–259. https://doi.org/10.1038/nn1632
DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281–285. https://doi.org/10.1016/0166-2236(90)90110-V
Dickens AM, Yoo SW, Chin AC, Xu J, Johnson TP, Trout AL, Hauser KF, Haughey NJ (2017) Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. Sci Rep 7(1):7748. https://doi.org/10.1038/s41598-017-07570-5
Dobbs LK, Kaplan AR, Lemos JC, Matsui A, Rubinstein M, Alvarez VA (2016) Dopamine regulation of lateral inhibition between striatal neurons gates the stimulant actions of cocaine. Neuron 90(5):1100–1113. https://doi.org/10.1016/j.neuron.2016.04.031
Duncan MJ, Bruce-Keller AJ, Conner C, Knapp PE, Xu R, Nath A, Hauser KF (2008) Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine. Am J Physiol Regul Integr Comp Physiol 295(5):R1680-1687. https://doi.org/10.1152/ajpregu.90496.2008
El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF (2005) Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50(2):91–106. https://doi.org/10.1002/glia.20148
El-Hage N, Bruce-Keller AJ, Yakovleva T, Bakalkin G, Knapp PE, Hauser KF (2008) Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF-κB trafficking and transcription. PLoS ONE 3(12):e4093
Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33. https://doi.org/10.1038/nrn2040
Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32(5):883–909
Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009) In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission. Synapse 63(3):181–185. https://doi.org/10.1002/syn.20594
Fields JA, Swinton MK, Soontornniyomkij B, Carson A, Achim CL (2020) Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. https://doi.org/10.1097/QAD.0000000000002506
Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhurst S, Gelbard HA (1996) Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 271(26):15303–15306. https://doi.org/10.1074/jbc.271.26.15303
Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177(3):1397–1410. https://doi.org/10.2353/ajpath.2010.090945
Fitting S, Ignatowska-Jankowska BM, Bull C, Skoff RP, Lichtman AH, Wise LE, Fox MA, Su J, Medina AE, Krahe TE, Knapp PE, Guido W, Hauser KF (2013) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biol Psychiatr 73(5):443–453. https://doi.org/10.1016/j.biopsych.2012.09.026
Fitting S, Knapp PE, Zou S, Marks WD, Bowers MS, Akbarali HI, Hauser KF (2014) Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload. J Neurosci 34(38):12850–12864. https://doi.org/10.1523/JNEUROSCI.5351-13.2014
Fitting S, McRae M, Hauser KF (2020) Opioid and neuroHIV comorbidity—current and future perspectives. J Neuroimmune Pharmacol 15(4):584–627. https://doi.org/10.1007/s11481-020-09941-8
Freudenreich O, Basgoz N, Fernandez-Robles C, Larvie M, Misdraji J (2012) Case 5–2012. A 39-year-old man with a recent diagnosis of HIV infection and acute psychosis. N Engl J Med 366(7):648–657. https://doi.org/10.1056/NEJMcpc1005311
Gagnon D, Petryszyn S, Sanchez MG, Bories C, Beaulieu JM, De Koninck Y, Parent A, Parent M (2017) Striatal neurons expressing D1 and D2 receptors are morphologically distinct and differently affected by dopamine denervation in mice. Sci Rep 7:41432. https://doi.org/10.1038/srep41432
Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H (2017) HIV, Tat and dopamine transmission. Neurobiol Dis 105:51–73. https://doi.org/10.1016/j.nbd.2017.04.015
Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Morgello S, National Neuro ATC (2012) The National NeuroAIDS tissue consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS ONE 7(9):e46178. https://doi.org/10.1371/journal.pone.0046178
Gendron L, Lucido AL, Mennicken F, O’Donnell D, Vincent J-P, Stroh T, Beaudet A (2006) Morphine and pain-related stimuli enhance cell surface availability of somatic δ-opioid receptors in rat dorsal root ganglia. J Neurosci 26(3):953–962. https://doi.org/10.1523/jneurosci.3598-05.2006
Gertler TS, Chan CS, Surmeier DJ (2008) Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci 28(43):10814–10824. https://doi.org/10.1523/jneurosci.2660-08.2008
Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9(1):63. https://doi.org/10.1186/1471-2377-9-63
Goldstein DS (2011) Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases. Endocr Regul 45(2):91–98. https://doi.org/10.4149/endo_2011_02_91
Gonek M, McLane VD, Stevens DL, Lippold K, Akbarali HI, Knapp PE, Dewey WL, Hauser KF, Paris JJ (2018) CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward. Brain Behav Immun 69:124–138. https://doi.org/10.1016/j.bbi.2017.11.006
Graybiel AM, Grafton ST (2015) The striatum: where skills and habits meet. Cold Spring Harb Perspect Biol 7(8):a021691. https://doi.org/10.1101/cshperspect.a021691
Green AJE, Giovannoni G, Hall-Craggs MA, Thompson EJ, Miller RF (2000) Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease. Sex Transm Infect 76(6):443. https://doi.org/10.1136/sti.76.6.443
Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF (2001) Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102(3):555–563. https://doi.org/10.1016/s0306-4522(00)00461-9
Hahn YK, Masvekar RR, Xu R, Hauser KF, Knapp PE (2015a) Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects. Curr Hiv Res 13(1):10–20. https://doi.org/10.2174/1570162x13666150311163733
Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE (2015b) Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct 220(2):605–623. https://doi.org/10.1007/s00429-013-0676-6
Hashiguchi M, Saito T, Hisanaga S-i, Hashiguchi T (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human Tau. J Biol Chem 277(46):44525–44530. https://doi.org/10.1074/jbc.M207426200
Hategan A, Masliah E, Nath A (2019) HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein. J Neurovirol 25(5):648–660. https://doi.org/10.1007/s13365-019-00736-z
Hauser KF, Knapp PE (2014) Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol 118:231–313. https://doi.org/10.1016/B978-0-12-801284-0.00009-9
Hauser KF, Stiene-Martin A, Mattson MP, Elde RP, Ryan SE, Godleske CC (1996) µ-Opioid receptor-induced Ca2+ mobilization and astroglial development: morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca2+-dependent mechanism. Brain Res 720(1–2):191–203. https://doi.org/10.1016/0006-8993(96)00103-5
Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE (2012) Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res 10(5):435–452
Henderson LJ, Johnson TP, Smith BR, Reoma LB, Santamaria UA, Bachani M, Demarino C, Barclay RA, Snow J, Sacktor N, McArthur J, Letendre S, Steiner J, Kashanchi F, Nath A (2019) Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy. AIDS 33(Suppl 2):S145-s157. https://doi.org/10.1097/qad.0000000000002268
Hermes DJ, Jacobs IR, Key MC, League AF, Yadav-Samudrala BJ, Xu C, McLane VD, Nass SR, Jiang W, Meeker RB, Ignatowska-Jankowska BM, Lichtman AH, Li Z, Wu Z, Yuan H, Knapp PE, Hauser KF, Fitting S (2020) Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids. J Neuroinflammation 17(1):345. https://doi.org/10.1186/s12974-020-01971-6
Hriso E, Kuhn T, Masdeu JC, Grundman M (1991) Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatr 148(11):1558–1561. https://doi.org/10.1176/ajp.148.11.1558
Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci USA 110(33):13588–13593. https://doi.org/10.1073/pnas.1308673110
Kadri F, Pacifici M, Wilk A, Parker-Struckhoff A, Del Valle L, Hauser KF, Knapp PE, Parsons C, Jeansonne D, Lassak A, Peruzzi F (2015) HIV-1-Tat protein inhibits SC35-mediated Tau exon 10 inclusion through up-regulation of DYRK1A kinase. J Biol Chem 290(52):30931–30946. https://doi.org/10.1074/jbc.M115.675751
Kesby JP, Markou A, Semenova S (2016a) The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice. Neuropharmacology 109:205–215. https://doi.org/10.1016/j.neuropharm.2016.06.011
Kesby JP, Markou A, Semenova S (2016b) Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice. Behav Brain Res 311:131–140. https://doi.org/10.1016/j.bbr.2016.05.034
Kesby JP, Najera JA, Romoli B, Fang Y, Basova L, Birmingham A, Marcondes MCG, Dulcis D, Semenova S (2017) HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function. Brain Behav Immun 65:210–221. https://doi.org/10.1016/j.bbi.2017.05.004
Lee M-s, Kwon YT, Li M, Peng J, Friedlander RM, Tsai L-H (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405(6784):360–364. https://doi.org/10.1038/35012636
Leibrand CR, Paris JJ, Ghandour MS, Knapp PE, Kim W-K, Hauser KF, McRae M (2017) HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice. Neurosci Lett 640:136–143
Leibrand CR, Paris JJ, Jones AM, Masuda QN, Halquist MS, Kim W-K, Knapp PE, Kashuba AD, Hauser KF, McRae M (2019) HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood–brain barrier integrity. J Neurovirol 25(4):560–577
Li GH, Maric D, Major EO, Nath A (2020) Productive HIV infection in astrocytes can be established via a nonclassical mechanism. AIDS 34(7):963–978. https://doi.org/10.1097/qad.0000000000002512
Ma YY, Cepeda C, Chatta P, Franklin L, Evans CJ, Levine MS (2012) Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons. ASN Neuro. https://doi.org/10.1042/an20110063
Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995) Human immunodeficiency virus type 1 tat activates non—N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37(3):373–380. https://doi.org/10.1002/ana.410370314
Markowitz JE, Gillis WF, Beron CC, Neufeld SQ, Robertson K, Bhagat ND, Peterson RE, Peterson E, Hyun M, Linderman SW, Sabatini BL, Datta SR (2018) The striatum organizes 3D behavior via moment-to-moment action selection. Cell 174(1):44-58 e17. https://doi.org/10.1016/j.cell.2018.04.019
Marks WD, Paris JJ, Schier CJ, Denton MD, Fitting S, McQuiston AR, Knapp PE, Hauser KF (2016) HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations. J Neurovirol 22(6):747–762. https://doi.org/10.1007/s13365-016-0447-2
Marks WD, Paris JJ, Barbour AJ, Moon J, Carpenter VJ, McLane VD, Lark ARS, Nass SR, Zhang J, Yarotskyy V, McQuiston AR, Knapp PE, Hauser KF (2021) HIV-1 Tat and morphine differentially disrupt pyramidal cell structure and function and spatial learning in hippocampal area CA1: continuous versus interrupted morphine exposure. eNeuro. https://doi.org/10.1523/eneuro.0547-20.2021
Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I, HNRC Group, The HIV Neurobehavioral Research Center (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42(6):963–972. https://doi.org/10.1002/ana.410420618
Mattos JPD, Rosso ALZ, Corrêa RB, Novis S (1993) Involuntary movements and AIDS: report on seven cases and review of the literature. Arq Neuropsiquiatr 51(4):491–497. https://doi.org/10.1590/s0004-282x1993000400011
McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson’s disease. Neuron 101(6):1042–1056. https://doi.org/10.1016/j.neuron.2019.03.004
McLaurin KA, Harris M, Madormo V, Harrod SB, Mactutus CF, Booze RM (2021) HIV-associated apathy/depression and neurocognitive impairments reflect persistent dopamine deficits. Cells. https://doi.org/10.3390/cells10082158
Meyer DA, Richer E, Benkovic SA, Hayashi K, Kansy JW, Hale CF, Moy LY, Kim Y, Callaghan JP, Tsai L-H, Greengard P, Nairn AC, Cowan CW, Miller DB, Antich P, Bibb JA (2008) Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. Proc Natl Acad Sci USA 105(47):18561. https://doi.org/10.1073/pnas.0806078105
Meyer VJ, Rubin LH, Martin E, Weber KM, Cohen MH, Golub ET, Valcour V, Young MA, Crystal H, Anastos K, Aouizerat BE, Milam J, Maki PM (2013) HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr 63(1):67–76. https://doi.org/10.1097/QAI.0b013e318289565c
Midde NM, Gomez AM, Zhu J (2012) HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J Neuroimmune Pharmacol 7(3):629–639. https://doi.org/10.1007/s11481-012-9369-9
Miller DR, Shaerzadeh F, Phan L, Sharif N, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H (2018) HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia 66(9):1915–1928. https://doi.org/10.1002/glia.23447
Mirsattari SM, Power C, Nath A (1998) Parkinsonism with HIV infection. Mov Disord 13(4):684–689. https://doi.org/10.1002/mds.870130413
Miura M, Masuda M, Aosaki T (2008) Roles of μ-opioid receptors in GABAergic synaptic transmission in the striosome and matrix compartments of the striatum. Mol Neurobiol 37(2):104–115. https://doi.org/10.1007/s12035-008-8023-2
Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR (2010) Innate immune recognition and activation during HIV infection. Retrovirology 7(1):54. https://doi.org/10.1186/1742-4690-7-54
Murphy A, Barbaro J, Martinez-Aguado P, Chilunda V, Jaureguiberry-Bravo M, Berman JW (2019) The effects of opioids on HIV neuropathogenesis. Front Immunol 10(2445):2445. https://doi.org/10.3389/fimmu.2019.02445
Narasipura SD, Kim S, Al-Harthi L (2014) Epigenetic regulation of HIV-1 latency in astrocytes. J Virol 88(5):3031–3038. https://doi.org/10.1128/jvi.03333-13
Nass SR, Hahn YK, McLane VD, Varshneya NB, Damaj MI, Knapp PE, Hauser KF (2020) Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male mice. Brain Behavior Immunity Health 5:100077. https://doi.org/10.1016/j.bbih.2020.100077
Nath A (2015) Eradication of human immunodeficiency virus from brain reservoirs. J Neurovirol 21(3):227–234. https://doi.org/10.1007/s13365-014-0291-1
Nath A, Geiger J (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 54(1):19–33. https://doi.org/10.1016/s0301-0082(97)00053-1
Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70(3):1475–1480
Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol (oxford, England) 14(3):222–227. https://doi.org/10.1177/026988110001400305
Neely MD, Schmidt DE, Deutch AY (2007) Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience 149(2):457–464. https://doi.org/10.1016/j.neuroscience.2007.06.044
Nelson AB, Kreitzer AC (2014) Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci 37:117–135. https://doi.org/10.1146/annurev-neuro-071013-013916
Nolan R, Gaskill PJ (2019) The role of catecholamines in HIV neuropathogenesis. Brain Res 1702:54–73. https://doi.org/10.1016/j.brainres.2018.04.030
Obermann M, Kuper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, Koutsilieri E, Arendt G, Diener HC, Maschke M, German Competence Network HIV/AIDS (2009) Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. J Neurol 256(6):948–953. https://doi.org/10.1007/s00415-009-5052-3
Ohene-Nyako M, Nass SR, Hahn YK, Knapp PE, Hauser KF (2021a) Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice. Neurosci Lett 741:135502. https://doi.org/10.1016/j.neulet.2020.135502
Ohene-Nyako M, Persons AL, Napier TC (2021b) Hippocampal blood–brain barrier of methamphetamine self-administering HIV-1 transgenic rats. Eur J Neurosci 53(2):416–429. https://doi.org/10.1111/ejn.14925
Oude Ophuis RJA, Boender AJ, van Rozen AJ, Adan RAH (2014) Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum. Front Neuroanat 8:14–14. https://doi.org/10.3389/fnana.2014.00014
Ouimet CC, Langley-Gullion KC, Greengard P (1998) Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res 808(1):8–12. https://doi.org/10.1016/S0006-8993(98)00724-0
Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, Everall IP, Masliah E (2011) Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol 178(4):1646–1661. https://doi.org/10.1016/j.ajpath.2010.12.033
Podhaizer EM, Zou S, Fitting S, Samano KL, El-Hage N, Knapp PE, Hauser KF (2012) Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol 7(4):877–891. https://doi.org/10.1007/s11481-011-9326-z
Pulliam L, Liston M, Sun B, Narvid J (2020) Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV. J Neurovirol 26(6):880–887. https://doi.org/10.1007/s13365-020-00877-6
Qi Y, Xu M, Wang W, Wang Y-Y, Liu J-J, Ren H-X, Liu M-M, Li R-L, Li H-J (2021) Early prediction of putamen imaging features in HIV-associated neurocognitive impairment syndrome. BMC Neurol 21(1):106. https://doi.org/10.1186/s12883-021-02114-x
Quizon PM, Sun WL, Yuan Y, Midde NM, Zhan CG, Zhu J (2016) Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Sci Rep 6(1):39048. https://doi.org/10.1038/srep39048
Rodman TC, Sullivan JJ, Bai X, Winston R (1999) The human uniqueness of HIV: innate immunity and the viral tat protein. Hum Immunol 60(8):631–639. https://doi.org/10.1016/S0198-8859(99)00052-X
Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Lecour H, Goncalves V, Paula-Barbosa MM (2000) AIDS does not alter the total number of neurons in the hippocampal formation but induces cell atrophy: a stereological study. Acta Neuropathol 99(6):643–653
Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Paula-Barbosa MM (2004) Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol 107(2):97–110. https://doi.org/10.1007/s00401-003-0781-3
Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991) Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 65(2):961–967
Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248. https://doi.org/10.1038/nrneurol.2016.27
Schier CJ, Marks WD, Paris JJ, Barbour AJ, McLane VD, Maragos WF, McQuiston AR, Knapp PE, Hauser KF (2017) Selective vulnerability of striatal D2 versus D1 dopamine receptor-expressing medium spiny neurons in HIV-1 Tat transgenic male mice. J Neurosci 37(23):5758–5769. https://doi.org/10.1523/JNEUROSCI.0622-17.2017
Severino AL, Mittal N, Hakimian JK, Velarde N, Minasyan A, Albert R, Torres C, Romaneschi N, Johnston C, Tiwari S, Lee AS, Taylor AM, Gavériaux-Ruff C, Kieffer BL, Evans CJ, Cahill CM, Walwyn WM (2020) μ-Opioid receptors on distinct neuronal populations mediate different aspects of opioid reward-related behaviors. eNeuro. https://doi.org/10.1523/eneuro.0146-20.2020
Sil S, Singh S, Chemparathy DT, Chivero ET, Gordon L, Buch S (2021) Astrocytes & astrocyte derived extracellular vesicles in morphine induced amyloidopathy: implications for cognitive deficits in opiate abusers. Aging Dis 12(6):1389–1408. https://doi.org/10.14336/AD.2021.0406
Silva JN, Polesskaya O, Wei HS, Rasheed I-YD, Chamberlain JM, Nishimura C, Feng C, Dewhurst S (2014) Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity. Microcirculation 21(7):664–676. https://doi.org/10.1111/micc.12145
Smith DB, Simmonds P, Bell JE (2014) Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users. J Neurovirol 20(1):28–38. https://doi.org/10.1007/s13365-013-0225-3
Solomons R, Slogrove A, Schoeman J, Marais B, van Zyl G, Maritz J, van Toorn R (2010) Acute extrapyramidal dysfunction in two HIV-infected children. J Trop Pediatr 57(3):227–231. https://doi.org/10.1093/tropej/fmq080
Stiene-Martin A, Mattson MP, Hauser KF (1993) Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation. Brain Res Dev Brain Res 76(2):189–196. https://doi.org/10.1016/0165-3806(93)90207-q
Stiene-Martin A, Zhou R, Hauser KF (1998) Regional, developmental, and cell cycle-dependent differences in μ, δ, and κ-opioid receptor expression among cultured mouse astrocytes. Glia 22(3):249–259. https://doi.org/10.1002/(SICI)1098-1136(199803)22:33.0.CO;2-0
Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R (2014) L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatr 75(9):711–722. https://doi.org/10.1016/j.biopsych.2013.05.006
Suzuki M, El-Hage N, Zou S, Hahn YK, Sorrell ME, Sturgill JL, Conrad DH, Knapp PE, Hauser KF (2011) Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death. Mol Neurodegener 6:78. https://doi.org/10.1186/1750-1326-6-78
Tolnay M, Probst A (1999) Tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25(3):171–187
Volkow ND, Morales M (2015) The brain on drugs: from reward to addiction. Cell 162(4):712–725. https://doi.org/10.1016/j.cell.2015.07.046
Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, Schwartz C (2019) Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infec Microbiol. https://doi.org/10.3389/fcimb.2019.00362
Wang J-Z, Xia Y-Y, Grundke-Iqbal I, Iqbal K (2013) Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 33:S123–S139. https://doi.org/10.3233/JAD-2012-129031
Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM (2016) Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS 30(11):1789–1794. https://doi.org/10.1097/qad.0000000000001103
Xu C, Fitting S (2016) Inhibition of GABAergic neurotransmission by HIV-1 Tat and opioid treatment in the striatum involves μ-opioid receptors. Front Neurosci 10:497. https://doi.org/10.3389/fnins.2016.00497
Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, Milani D, Dowd DR, Capitani S, Vitale M (2000) HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 275(6):4159–4165. https://doi.org/10.1074/jbc.275.6.4159
Zhu J, Mactutus CF, Wallace DR, Booze RM (2009) HIV-1 Tat protein-induced rapid and reversible decrease in 3H dopamine uptake: dissociation of 3H dopamine uptake and 3H 2β-carbomethoxy-3-β-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J Pharmacol Exp Ther 329(3):1071–1083. https://doi.org/10.1124/jpet.108.150144
Zhu J, Ananthan S, Zhan CG (2018) The role of human dopamine transporter in NeuroAIDS. Pharmacol Ther 183:78–89. https://doi.org/10.1016/j.pharmthera.2017.10.007
Zou S, Fitting S, Hahn YK, Welch SP, El-Hage N, Hauser KF, Knapp PE (2011) Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia. Brain 134(Pt 12):3616–3631. https://doi.org/10.1093/brain/awr281
Ztaou S, Maurice N, Camon J, Guiraudie-Capraz G, Kerkerian-Le Goff L, Beurrier C, Liberge M, Amalric M (2016) Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson’s disease. J Neurosci 36(35):9161–9172. https://doi.org/10.1523/jneurosci.0873-16.2016
US